Diagnosing an Underperforming Drug

When a mid-sized biopharmaceutical company launched a new hormone replacement product into the market, they expected huge success. But it quickly became obvious; the drug wasn’t performing up to its potential. What wasn’t clear was why.  Learn how Quintiles biopharmaceutical consulting uncovered barriers to success and helped optimize the customer's sales and marketing strategy.